PROVIDER PROFILE · NPI 1427121896

Peter Navolanic

PRACTICELA CLINICA DE LA RAZA INCSee all providers at this practice →

Family PracticeVallejo, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

129

Beneficiaries

—

Total drug cost

$21K

Distinct drugs

Brand share

34.9%

Top prescribed drugs

Omeprazole18 claims

Semaglutide17 claims

Oxycodone Hcl/Acetaminophen16 claims

Amlodipine Besylate15 claims

Hydrochlorothiazide14 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$25

Payment records

By payment type

Food and Beverage$25

Top paying entities

Food and Beverage$25

REFERRAL NETWORK

Where Peter Navolanic's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
LA CLINICA DE LA RAZA INC	24	45
Unilab Corporation Clinical Laboratory · Sacramento, CA	14	52

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history